Spravato® for depression that hasn’t let up
An FDA-approved nasal spray for adults with treatment-resistant depression, given in a private room with clinical supervision.
What is Spravato?
Spravato® (esketamine) is derived from ketamine and is designed to ease depression symptoms quickly, particularly when standard antidepressants haven’t helped enough. Because of how it works, it’s only given in a certified medical setting, where you stay under observation during each session.
Our psychiatric providers Roseline Yang and Alisha Bauman oversee Spravato care.
Three steps to treatment
Spravato FAQ
Who is Spravato for?
Adults with depression that hasn’t improved enough with other treatments. Your consultation will confirm whether you’re a candidate.
How often are sessions?
Typically twice a week for the first four weeks, then less often depending on your response.
Is it covered by insurance?
Many plans cover it. We check your benefits before you start.
Can I drive home afterwards?
No. Plan for someone to drive you home after each session.
Ask about Spravato
Request a consultation with Roseline Yang or Alisha Bauman.